Landos Biopharma, Inc.
LABPDelisted May 23, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001785345
Landos Biopharma, Inc. was delisted on May 23, 2024; its insiders filed their last Form 4 on May 23, 2024; 16 institutions reported holding it in 13F filings for Q1 2024, worth $34.9M in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Landos Biopharma, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 35 | 31 | −4 |
| Shares | 22.5M | 21.6M | −861.2K (−3.8%) |
| Value | $16.4M | $14.0M | −$2.31M (−14.1%) |
New holders (5)
Institutions that held Landos Biopharma, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Green Square Capital Advisors LLC | 84,500 | $55.0K | 0.01% |
| Balyasny Asset Management LLC | 15,687 | $10.0K | 0.00% |
| Man Group plc | 14,387 | $9.00K | 0.00% |
| BNP Paribas Arbitrage, SA | 1,122 | $729 | 0.00% |
| China Universal Asset Management Co., Ltd. | 377 | $0 | 0.00% |
Sold out (9)
Institutions that held Landos Biopharma, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Ergoteles LLC | 22,900 | $17.0K |
| Citadel Advisors LLC | 21,119 | $16.0K |
| Jane Street Group, LLC | 20,957 | $15.0K |
| Susquehanna International Group, LLP | 12,529 | $9.00K |
| Raymond James & Associates | 10,350 | $8.00K |
| Allworth Financial LP | 5,286 | $4.00K |
| UBS Group AG | 1,243 | $1.00K |
| Credit Suisse AG | 3 | $0 |
| Advisor Group Holdings, Inc. | 418 | $0 |